1. Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
    Stefan Kasper et al, 2020, Clinical Colorectal Cancer CrossRef
  2. An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
    Giulia Fornasier et al, 2018, Advances in Therapy CrossRef
  3. Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis
    Aparna R Parikh et al, 2022, The Oncologist CrossRef
  4. Radiomics in Oncological PET/CT: Clinical Applications
    Jeong Won Lee et al, 2018, Nuclear Medicine and Molecular Imaging CrossRef
  5. Effects of different administration strategies of cetuximab on remission rate, MMPs, miR-106b-5p, PCAT-1, and adverse reactions in patients with RAS wild-type CRC liver metastasis
    Chao Wang et al, 2022, World Chinese Journal of Digestology CrossRef
  6. A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
    Kathleen N. Moore et al, 2021, Targeted Oncology CrossRef